Transverse Relaxation Time Constant of Cystathionine in Human Glioma at 3 T
Magnetic Resonance in Medicine · 2026-09 · 96 (3) · 1076-1082
DOI: 10.1002/mrm.70430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, online erschienen am 20.05.2026. Verfasst von Dinesh K Deelchand und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Cystathionine, Magnetic Resonance Imaging. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NIH HHS, Investissements d'avenir.
Abstract (Originalsprache)
Purpose
Cystathionine (Cth) has emerged as a promising biomarker for identifying 1p/19q codeleted gliomas. However, little is known about the T 2 relaxation time constant of Cth in gliomas. The aim of this study was to measure the T 2 of Cth in vivo in glioma and compare it to the T 2 s of other metabolites at 3 T.
Methods
Ten participants with glioma were scanned at 3 T. Single‐voxel proton PRESS spectra were acquired at four echo‐times to determine the T 2 relaxation time constants of Cth, N ‐acetylaspartate, scyllo ‐inositol, total creatine, and total choline. Processed spectra were analyzed using LCModel, and the results were fitted using a mono‐exponential function to estimate the T 2 relaxation time constants. T 2 of Cth was also measured using high‐resolution NMR.
Results
The T 2 of Cth varied across participants (42–128 ms, with a mean and standard deviation of 75 ± 24 ms). Additionally, T 2 relaxation time constants of Cth were shorter than those of singlets measured in glioma in the same participants. Distinct differences in T 2 between the CH and CH 2 proton groups in Cth were also observed both in vitro and in vivo.
Conclusion
Knowledge of the T 2 of Cth should improve its quantification and may help increase understanding of the intracellular environment in glioma cells, potentially providing insights into tumor metabolism in future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, USA.
- Paris Brain Institute - ICM, INSERM U 1127, CNRS UMR 7225, Sorbonne University, Équipe labelisée LNCC, Paris, France.
- Department of Chemistry, University of Miami, Coral Gables, Florida, USA.
- Sorbonne University, AP-HP, Paris Brain Institute - ICM, La Pitié Salpêtrière University Hospital - Charles Foix, Paris, France.
ORCID-Profile: Dinesh K Deelchand, Francesca Branzoli, Małgorzata Marjańska
Förderung
- NIBIB NIH HHS
- NIH HHS
- Investissements d'avenir
- Agence Nationale de la Recherche
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Deelchand, D. K., Branzoli, F., Walls, J. D., Nichelli, L., Sanson, M., Mathon, B., & Marjańska, M. (2026). Transverse Relaxation Time Constant of Cystathionine in Human Glioma at 3 T. Magnetic Resonance in Medicine, 96(3), 1076-1082. https://doi.org/10.1002/mrm.70430
Vancouver
Deelchand DK, Branzoli F, Walls JD, Nichelli L, Sanson M, Mathon B, et al. Transverse Relaxation Time Constant of Cystathionine in Human Glioma at 3 T. Magnetic Resonance in Medicine. 2026;96(3):1076-1082. doi:10.1002/mrm.70430
BibTeX
@article{Deelchand2026,
author = {Deelchand, Dinesh K and Branzoli, Francesca and Walls, Jamie D and Nichelli, Lucia and Sanson, Marc and Mathon, Bertrand and Marjańska, Małgorzata},
title = {Transverse Relaxation Time Constant of Cystathionine in Human Glioma at 3 T},
journal = {Magnetic Resonance in Medicine},
year = {2026},
volume = {96},
number = {3},
pages = {1076--1082},
doi = {10.1002/mrm.70430}
}
EUVIMED